Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Journal of Personalized Medicine|December 24, 2021
Predictors of Efavirenz Plasma Exposure, Auto-Induction Profile, and Effect of Pharmacogenetic Variations among HIV-Infected Children in Ethiopia: A Prospective Cohort StudyAdugna Chala, Birkneh Tilahun Tadesse, Tolossa Eticha Chaka, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 2018
Relationship between In Vivo CYP3A4 Activity, CYP3A5 Genotype, and Systemic Tacrolimus Metabolite/Parent Drug Ratio in Renal Transplant Recipients and Healthy VolunteersThomas Vanhove, Hylke de Jonge, Henriëtte de Loor, et al.
Thrombosis Research|March 7, 2015
Does the Russell Viper Venom time test provide a rapid estimation of the intensity of oral anticoagulation? A cohort studyJonathan Douxfils, Bernard Chatelain, Paul Hjemdahl, et al.
Thrombosis and Haemostasis|December 19, 2014
Estimation of dabigatran plasma concentrations in the perioperative setting. An ex vivo study using dedicated coagulation assaysJonathan Douxfils, Sarah Lessire, Anne-Sophie Dincq, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 18, 2016
High Rate of Treatment Failures in Nonimmune Travelers Treated With Artemether-Lumefantrine for Uncomplicated Plasmodium falciparum Malaria in Sweden: Retrospective Comparative Analysis of Effectiveness and Case SeriesKlara Sondén, Katja Wyss, Irina Jovel, et al.
Thrombosis Research|May 19, 2015
Clinical evaluation of laboratory methods to monitor apixaban treatment in patients with atrial fibrillationMika Skeppholm, Fadiea Al-Aieshy, Maria Berndtsson, et al.
Basic & Clinical Pharmacology & Toxicology|November 25, 2016
Oil-Fortified Maize Porridge Increases Absorption of Lumefantrine in Children with Uncomplicated Falciparum MalariaNorah Mwebaza, Markus Jerling, Lars L Gustafsson, et al.
European Journal of Clinical Pharmacology|June 21, 2013
Evaluation of coagulation assays versus LC-MS/MS for determinations of dabigatran concentrations in plasmaJovan P Antovic, Mika Skeppholm, Jaak Eintrei, et al.
British Journal of Clinical Pharmacology|October 9, 2024
Sub- and supratherapeutic efavirenz plasma concentrations with risk for HIV therapy failure are mainly genetically explained in Ugandan children: The prospective GENEFA cohort studySandra Soeria-Atmadja, Pauline Amuge, Sarah Nanzigu, et al.
Frontiers in Pharmacology|May 11, 2026
Efavirenz metabolism and CNS toxicity in Ugandan children: impact of CYP2B6 genotype and plasma metabolite profilesSandra Soeria-Atmadja, Madeleine Pettersson Bergstrand, Pauline Amuge, et al.
Pageof 6